HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A novel de novo STXBP1 mutation is associated with mitochondrial complex I deficiency and late-onset juvenile-onset parkinsonism.

Abstract
Mutations in STXBP1 have recently been identified as a cause of infantile epileptic encephalopathy. The underlying mechanism of the disorder remains unclear and, recently, several case reports have described broad and progressive neurological phenotypes in addition to early-onset epilepsy. Herein, we describe a patient with early-onset epilepsy who subsequently developed a progressive neurological phenotype including parkinsonism in her early teens. A de novo mutation in STXBP1 (c.416C>T, p.(Pro139Leu)) was detected with exome sequencing together with profound impairment of complex I of the mitochondrial respiratory chain on muscle biopsy. These findings implicate a secondary impairment of mitochondrial function in the progressive nature of the disease phenotype.
AuthorsMichael J Keogh, D Daud, A Pyle, J Duff, H Griffin, L He, C L Alston, H Steele, S Taggart, A P Basu, R W Taylor, R Horvath, V Ramesh, Patrick F Chinnery
JournalNeurogenetics (Neurogenetics) Vol. 16 Issue 1 Pg. 65-7 (Jan 2015) ISSN: 1364-6753 [Electronic] United States
PMID25418441 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Munc18 Proteins
  • STXBP1 protein, human
  • Electron Transport Complex I
Topics
  • Brain (physiopathology)
  • Child
  • Disease Progression
  • Electroencephalography
  • Electron Transport Complex I (deficiency, genetics)
  • Epilepsy (complications, genetics)
  • Exome
  • Female
  • Humans
  • Mitochondrial Diseases (complications, genetics)
  • Munc18 Proteins (genetics)
  • Mutation, Missense
  • Parkinsonian Disorders (complications, genetics)
  • Phenotype

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: